The UC Davis MIND Institute’s Distinguished Lecturer series focuses on research and innovation in care for people with neurodevelopmental conditions. The free events are open to all.
First global trial shows tumor DNA-guided cancer therapy is safe and effective, improving outcomes through personalized drug combinations in oncology care.
UC Davis Medical Center is the first hospital in Northern California to use a new nerve stimulation device to treat moderate to severe obstructive sleep apnea.
A new paper from researchers at the BulletPoints Project outlines why conversations about firearms belong in the exam room and how clinicians can approach the sensitive subject with their patients.
Only after becoming pregnant did Darlene Hildebrandt realize her congenital neurological condition threatened two lives — hers and her developing baby’s — until UC Davis Health doctors intervened.
Health Media Contacts
Find the best contact for health-related media inquiries.
